These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3816575)
1. The project leader for new drug development. Hull JH Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 2):131-4. PubMed ID: 3816575 [No Abstract] [Full Text] [Related]
2. Developing drug prototypes: pharmacology replaces safety and tolerability? Cohen AF Nat Rev Drug Discov; 2010 Nov; 9(11):856-65. PubMed ID: 20847743 [TBL] [Abstract][Full Text] [Related]
3. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
4. Drug discovery-background and foreground. Tishler M Clin Pharmacol Ther; 1973; 14(4):479-86. PubMed ID: 4723254 [No Abstract] [Full Text] [Related]
6. Systems pharmacology to predict drug safety in drug development. Trame MN; Biliouris K; Lesko LJ; Mettetal JT Eur J Pharm Sci; 2016 Oct; 94():93-95. PubMed ID: 27251780 [TBL] [Abstract][Full Text] [Related]
7. The development of drugs and the responsibilities involved. Weston JK Ann N Y Acad Sci; 1967 Mar; 141(1):24-34. PubMed ID: 5232235 [No Abstract] [Full Text] [Related]
8. Clinical pharmacology and orphan drugs: an informational inventory 2006-2010. Bashaw ED; Fang L Clin Pharmacol Ther; 2012 May; 91(5):932-6. PubMed ID: 22453190 [TBL] [Abstract][Full Text] [Related]
10. The current status of guidelines for clinical research from the viewpoint of the pharmaceutical industry. Dixon RB J Clin Pharmacol; 1977; 17(11-12):691-6. PubMed ID: 925189 [No Abstract] [Full Text] [Related]
11. Toxicity of new drugs. Lowinger P Science; 1968 Aug; 161(3842):632. PubMed ID: 5664503 [No Abstract] [Full Text] [Related]
12. Plans to reduce drug risks examined. Young D Am J Health Syst Pharm; 2007 Aug; 64(15):1568, 1574, 1578. PubMed ID: 17646555 [No Abstract] [Full Text] [Related]
15. US FDA seeks more pharmaceutical industry cash. Zwillich T Lancet; 2007 Feb; 369(9559):357. PubMed ID: 17283497 [No Abstract] [Full Text] [Related]
16. Drug development and the FDA's Critical Path Initiative. Woosley RL; Cossman J Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012 [TBL] [Abstract][Full Text] [Related]
17. Drug risks and benefits poorly communicated, experts contend. Young D Am J Health Syst Pharm; 2006 Jul; 63(14):1312, 1314. PubMed ID: 16809749 [No Abstract] [Full Text] [Related]
18. The future of clinical pharmacology in the UK. Breckenridge A; Dollery C; Rawlins M; Walport M Lancet; 2006 Apr; 367(9516):1051. PubMed ID: 16581393 [No Abstract] [Full Text] [Related]
19. Clinical pharmacology. Blue-chip technology. Flockhart DA; Webb DJ Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV2. PubMed ID: 9872149 [No Abstract] [Full Text] [Related]
20. Industry promotion of unlabeled uses. Schwarz LR Am J Health Syst Pharm; 2008 May; 65(10):908-10. PubMed ID: 18463338 [No Abstract] [Full Text] [Related] [Next] [New Search]